Gene: TMEM92
Official Full Name: transmembrane protein 92provided by HGNC
Gene Summary: Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13277 | TMEM92 Knockout cell line (HeLa) | Human | TMEM92 | 1:3~1:6 | Negative | Online Inquiry |
KO13278 | TMEM92 Knockout cell line (HCT 116) | Human | TMEM92 | 1:2~1:4 | Negative | Online Inquiry |
KO13279 | TMEM92 Knockout cell line (A549) | Human | TMEM92 | 1:3~1:4 | Negative | Online Inquiry |
TMEM92 Gene Knockout Cell Lines are a specialized tool for researchers interested in studying the elusive functions of the TMEM92 gene, which is implicated in various cellular processes, including the regulation of cellular stress responses and immune functions. By utilizing CRISPR/Cas9 gene editing technology, these cell lines provide a robust platform for generating precisely edited genomic sequences where the TMEM92 gene is effectively knocked out, allowing for comprehensive studies of the resultant phenotypic changes.
The core mechanism of action for the TMEM92 Gene Knockout Cell Lines lies in the selective disruption of the target gene, resulting in the loss of protein expression. This knockout model is instrumental in dissecting the biological pathways associated with TMEM92 by providing insights into cellular metabolism, signaling cascades, and potential dysregulations that may lead to pathological states.
The scientific importance of these cell lines extends to various research applications, particularly in the fields of immunology, cancer biology, and molecular genetics. They serve as invaluable models for elucidating the role of TMEM92 in immune responses and tumorigenesis, thus offering potential pathways for therapeutic targeting in clinical settings.
Compared to conventional gene knockout methods, TMEM92 Gene Knockout Cell Lines offer superior precision, efficiency, and reproducibility due to the advanced CRISPR/Cas9 technology employed. This innovative approach not only reduces off-target effects but also accelerates the timeline for experimental validation, empowering researchers with more reliable and actionable data.
For researchers and clinicians alike, the value of TMEM92 Gene Knockout Cell Lines cannot be overstated. They facilitate a deeper understanding of gene function and enable the exploration of novel therapeutic strategies, making them an essential asset in the rapidly advancing landscape of genetic research and personalized medicine.
Our company prides itself on its expertise in producing high-quality genetic tools that empower scientific discovery. With a commitment to cutting-edge technology and innovative solutions, we strive to support the research community in advancing biological knowledge and improving human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.